Christian Reinhard

IBDoc in Australia

IBDoc TGA approved for Australia

IBDoc® is now available in Australia. IBDoc® achieved the CE certification in April 2015 for self-testing making it available to patients throughout Europe. Now a second major milestone has been reached. The Australian Health Authorities TGA (Therapeutic Goods Administration), approved the use of IBDoc®. This means that IBDoc® can now be made available to all Australian IBD patients

Calprotectin Video from CDHF

The Canadian Digestive Health Foundation (CDHF) has recently produced a very interesting video about the use of calprotectin to confirm and predict flares in inflammatory bowel disease patients and how it can be used to manage IBD. By loading the video, you agree to YouTube’s privacy policy.Learn more Load video Always unblock YouTube

UEGW 2015 News

  This year the United European Gastroenterology Week took place from October 24th to 28th in Barcelona. Over 13 000 participants from 114 countries were present. The BÜHLMANN team was among the 2325 exhibitors. This year’s UEGW marked an important event for us with the publication of the first clinical usability evaluation  of IBDoc®. The data …

UEGW 2015 News Read More »

BÜHLMANN launches IBDoc® – the first CE marked Calprotectin Home Test

Basel, April 2nd, 2015 – BÜHLMANN is pleased to announce the launch of IBDoc®, the first in-vitro diagnostic test to measure the fecal inflammation marker calprotectin at home. IBDoc® just received a  CE mark for patient self testing and is a revolutionary new test for gut inflammation aimed at people with Inflammatory Bowel Disease, Crohn’s and Ulcerative Colitis …

BÜHLMANN launches IBDoc® – the first CE marked Calprotectin Home Test Read More »